nlvpartners  funding the healthcare revolution new leaf venture partners funding the healthcare revolution bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version new leaf ventures ii lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors new leaf ventures ii lp check out list of companies and businesses related to new leaf ventures ii lp find out new leaf ventures ii lp address and contact details view other people related to new leaf ventures ii lp  coworkers colleagues companions etc address co new leaf venture mgmt ii llc times square twr  times sq ste  new york  ny companies related to new leaf ventures ii lp cikcompany namepositioncompany addressworld heart corp wiley post way suite  salt lake city mei pharma inc owner  el camino real suite  san diego irhythm technologies inc owner  townsend street suite  san francisco durata therapeutics inc south wacker drive suite  chicago  new leaf ventures ii lp on the web persons related to new leaf ventures ii lp  world heart corpnamepositioncityabiomed inc owner danversabiomed inc owner danverssrinivas akkarajumenlo parkhove anderssalt lake citymarxe austinsalt lake citysteven r beckerdallasmorgan r brownexec vp and cfo oaklandmorgan r brownexec vp and cfo salt lake citymorgan r brownexecutive vp salt lake citycamber capital management llcbostoncamber capital management llc owner bostonjohn f carlsonst paul mnphilippe chambonnew yorkphilippe chambonnew yorkphilippe o chambonnew yorkgayla j comptonpalo altokevin r comptonpalo altojeani delagardellemenlo parkjeani delagardelledirector salt lake cityjeani delagardelledirector menlo parkjeani delagardelledirector salt lake cityjeani delagardelledirector salt lake citymichael sumner estesdirector oaklandmichael sumner estesdirector salt lake citymichael sumner estesdirector salt lake cityjones eugenesalt lake citywilliam c garriocktoronto on canadawilliam c garriockdirector oaklandwilliam c garriockdirector salt lake citywilliam c garriockdirector salt lake citywilliam c garriockdirector salt lake citygary w goertzdirector oaklandgary w goertzdirector salt lake cityd mark goudievp finance  cfo stittsville on canadaanders d hovedirector new yorkanders d hovedirector palo altoronald huntnew yorkronald huntnew yorkjassawalla jalsalt lake citypiet jansen nl amsterdam netherlandspiet jansenchief medical officer oaklandjal s jassawallapresident  ceo orindajal s jassawallapresident  ceo oaklandjal s jassawallaexec vp and cto oaklandjal s jassawallaexec vp and cto salt lake cityjal s jassawallaexec vp and cto salt lake citydelagardelle jeanisalt lake citymartin johnsalt lake cityeugene b jonesdirector salt lake cityeugene b jonesdirector salt lake citya richard juelisoaklanda richard juelischief financial officer oaklandpratap khanwilkarsalt lake citypratap khanwilkarvp rotary systems and bus dev oaklandpratap khanwilkarvice president oaklandpratap khanwilkarvp rotary systems  bus dev salt lake citykathleen laportemenlo parkvijay k lathimenlo parkvijay k lathimenlo parkrobert j majtelespiedmontrobert j majtelesdirector oaklandjohn marinchakwalnut creekjohn alexander martinceo  president oaklandjohn alexander martinpresident and ceo salt lake cityjohn alexander martinpresident and ceo salt lake cityaustin w marxedirector new yorkaustin w marxedirector salt lake citymarxe austin w  greenhouse david m owner new yorkmarxe austin w  greenhouse david m owner new yorkmaverick venture management llc owner palo altomedquest products incsalt lake citymedquest products inc owner salt lake cityestes michaelsalt lake cityestes phd michaelsalt lake cityphillip millervp research  development berkeleyphillip millervp research  development oaklandphillip millervice president oaklandmichael r minoguesalt lake citybrown morgansalt lake citynew leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf venture management ii llcnew yorknew leaf venture management ii llcnew yorkjames niedelnew yorkjames niedelnew yorkdavid pellonechief financial officer oaklandmiller phillipsalt lake citykhanwilkar pratapsalt lake cityc ian rosscollingwood on canadac ian rossdirector oaklandmichael roth owner st francisg stacy smithdallasg stacy smithdallasg stacy smithdallassrb management lpdallasbrian jay starkst francisbrian jay starkst francisjohn j vajdavp manufacturing oaklandjohn j vajdavp manufacturing oaklandvef management v llcpalo altovef management v llcpalo altovenrock associates v lppalo altovenrock associates v lp owner palo altovenrock entrepreneurs fund v lppalo altovenrock entrepreneurs fund v lppalo altovenrock management v llcpalo altovenrock management v llcpalo altovenrock partners management v llcpalo altovenrock partners management v llcpalo altovenrock partners v l ppalo altovenrock partners v l ppalo altopatrick p walkerdallaspatrick p walkerdallaspatrick p walkerdallasreid s walkerdallasreid s walkerdallasreid s walkerdallasreid s walkerdallaswalker smith capital l p owner dallaswalker smith capital qp l pdallaswalker smith international fund ltddallaswalker smith international ltddallaswalker smith international ltddallaswalker smith international ltddallasgarriock williamsalt lake cityjohn woodardsenior vp of scientifc affairs salt lake cityws capital llc owner dallasws capital llc owner dallasws capital management lpdallasws capital management lpdallasws capital management lpdallasws opportunity fund international ltddallasws opportunity fund international ltddallasws opportunity fund international ltddallasws opportunity fund international ltddallasws opportunity fund l pdallasws opportunity fund qp l pdallasws ventures management l pdallasws ventures management l pdallasws ventures management l pdallasmanagement l l c wsvdallasmanagement l l c wsvdallasmanagement l l c wsvdallaspersons related to new leaf ventures ii lp  mei pharma incnamepositioncitysrinivas akkarajumenlo parkjosiah t austin owner dallascharles v baltic iiidirector san diegocharles v baltic iiidirector san diegocharles v baltic iiisan diegocharles v baltic iiidirector san diegocharles v baltic iiisan diegocharles v baltic iiidirector san diegostephen breckenridgenorth ryde nsw williams bryansan diegoleah rush canndirector san diegoleah rush canndirector san diegoleah rush canndirector san diegoleah rush canndirector san diegophilippe chambonsunnyvalephilippe o chambonnew yorkwhite christinesan diegokevan clemensdirector charlottekevan clemensdirector san diegogold danielsan diegokretser david morritz denorth ryde nsw jeani delagardellemenlo parkjeani delagardellemenlo parkbrian g drazbachief financial officer irvineel coronado holdings llcdallasnicholas gloverdirector san diegonicholas gloverdirector san diegonicholas gloverdirector san diegodaniel p phd goldchief executive officer san diego cadaniel p phd goldnew south walesdaniel p phd goldchief executive officer san diegodaniel p phd goldchief executive officer san diegodaniel p phd goldchief executive officer san diegoronald huntnew yorkronald huntnew yorkphilip a johnstonnorth ryde nsw philip a johnstondirector north ryde nswgraham e kellynorth ryde nsw vijay k lathimenlo parkvijay k lathimenlo parkcann leahsan diegorobert d masschief medical officer san diegorobert d masschief medical officer san diegorobert d masschief medical officer san diegochristopher naughtonnorth ryde nsw christopher naughtonceo  president north ryde nswpaul j nestelnorth ryde nsw new leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf venture management ii llcnew yorknew leaf venture management ii llcnew yorkjames niedelnew yorknovogen ltdsydneynovogen ltd owner north ryde nswnovogen ltd owner north ryde nswnovogen ltd owner north ryde nswliam ratcliffenew yorkliam ratcliffenew yorkthomas c reynoldsdirector bothellthomas c reynoldsdirector san diegothomas c reynoldsdirector san diegowilliam dodge rueckertdirector hendersonwilliam dodge rueckertdirector north ryde nswwilliam dodge rueckertdirector san diegowilliam dodge rueckertdirector san diegowilliam dodge rueckertdirector san diegowilliam dodge rueckertdirector san diegodavid r seatonnorth ryde nsw david r seatoncfo  secretary north ryde nswzech thomassan diegodavid m ursosr vp and general counsel san diegodavid m ursosr vp and general counsel san diegovivo ventures fund v lppalo altovivo ventures fund v lppalo altovivo ventures fund vii lppalo altovivo ventures fund vii lppalo altovivo ventures v affiliates fund lppalo altovivo ventures v affiliates fund lppalo altovivo ventures v llc owner palo altovivo ventures v llc owner palo altovivo ventures vii affiliates fund lppalo altovivo ventures vii affiliates fund lppalo altovivo ventures vii affiliates fund lppalo altovivo ventures vii llc owner palo altovivo ventures vii llc owner palo altochristine anna whitedirector san diegochristine anna whitedirector san diegochristine anna whitedirector san diegochristine anna whitedirector san diegorueckert williamsan diegobryan williamsnorth ryde nswbryan williamsdirector north ryde nswbryan williamsdirector san diegobryan williamsdirector san diegothomas m zechchief financial officer new south walesthomas m zechchief financial officer san diegothomas m zechchief financial officer san diegothomas m zechchief financial officer san diegothomas m zechchief financial officer san diegopersons related to new leaf ventures ii lp  irhythm technologies incnamepositioncitytiba aynechisan franciscobruce g bodakendirector san mateode clercq caspersan franciscode clercq caspersan franciscophilippe chambonsunnyvalegrant chrissan franciscojeffrey crowepalo altoclercq casper l dedirector palo altojeani delagardellemenlo parkmatthew c garrettchief financial officer san franciscopromod haquemead hardwinsan franciscomatthew d howardpalo altoronald huntnew yorkmudit k jainportola valleygreen joshuasan franciscogreen joshuasan franciscolenane judithsan franciscoking kevinsan franciscoking kevinsan franciscokevin m kingpresident and ceo santa claravijay k lathidirector menlo parkgarrett matthewsan franciscogoldberg michaelsan franciscogoldberg michaelmenlo parknew leaf venture associates ii lpnew yorknew leaf venture management ii llcnew yorknorwest venture partners xi lp owner minneapolisnorwest venture partners xii lppalo altoas novo owner bagsvaerdhardwin mead rsan franciscomead rsan franciscoliam ratcliffenew yorkscott raymondsan franciscokatz robertasan franciscokatz robertasan franciscokatz robertasan franciscomark j rubashdirector san josebrasch samsan franciscobrasch samsan franciscoraymond w scottdirector san franciscoguyer shellysan franciscoguyer shellysan franciscoralph snydermandirector richard s stackportola valleywilliam n starling jrpocatellojohnson stevesan franciscoderrick sungsee remarks san franciscosynergy life science partners l p owner portola valleysynergy venture partners llcportola valleyabhijit y talwalkardirector santa claraaynechi tibasan franciscokumar udaysan franciscokumar udaysan franciscolathi vijaysan franciscolathi vijaysan franciscodavid a vortevp sales san franciscowillis williamsan franciscostarling williamsan franciscostarling williamsan franciscostarling williamportola valleywillis williamsan franciscopersons related to new leaf ventures ii lp  durata therapeutics incnamepositioncitybrenton karl ahrensdirector westportbrenton karl ahrensdirector westportaisling capital iii lp owner new yorkaisling capital iii lp owner new yorkaisling capital partners iii llcnew yorkaisling capital partners iii llcnew yorkaisling capital partners iii lpnew yorkaisling capital partners iii lpnew yorksrinivas akkarajumenlo parksrinivas akkarajumenlo parksusan roberta allenmorristownangela gurski birchlermorristownjames c blair owner princetoneric buatoismenlo parkcanaan management incwestportcanaan management incwestportcanaan partners viii llcwestportcanaan partners viii llcwestportcanaan viii lpdirector westportcanaan viii lpdirector westportj martin carrolldirector chicagoj martin carrolldirector chicagophilippe o chambonnew yorkphilippe o chambonnew yorkphilippe o chambonnew yorkschutter richard u dedirector chicagoschutter richard u demorristownschutter richard u dedirector chicagoschutter richard u dedirector chicagojeani delagardellemenlo parkjeani delagardellemenlo parkjeani delagardellenew yorkassociates domain owner princetondomain partners viii lp owner princetonbrian h dovey owner princetondp viii associates lp owner princetonmichael w dunnechief medical officer morristownmichael w dunnechief medical officer chicagomichael w dunnechief medical officer chicagopaul r edickchief executive officer morristownpaul r edickchief executive officer chicagopaul r edickchief executive officer chicagosteve elmsnew yorksteve elmsnew yorkcorey n fishmancoo  cfo morristowncorey n fishmancfo  coo chicagocorey n fishmancfocoo chicagopaul a friedmandirector chicagopaul a friedmandirector chicagolisa m gilesdirector chicagolisa m gileschicagolisa m gilesdirector chicagodov a md goldsteindirector new yorkbrian k halak owner princetonjames healydirector menlo parkjames healymenlo parkgeorge f horner iiidirector morristownronald huntnew yorkronald huntdirector new yorkronald huntnew yorkkim p kamdarprincetonmilan kovacevicmorristownjeremy david lackmorristownvijay k lathimenlo parkvijay k lathimenlo parkvijay k lathinew yorknew leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf venture management ii llcnew yorknew leaf venture management ii llcnew yorknew leaf venture management ii llcnew yorkjames niedelnew yorkjames niedelnew yorkkevin c oboyledirector chicagokevin c oboyledirector chicagokevin c oboylemorristownbenjamin manlaui pemorristownbenjamin manlavi pechicagomichael powellmenlo parkdennis j purcellnew yorkdennis j purcellnew yorkliam ratcliffenew yorkandrew n schiffnew yorkandrew n schiffnew yorkkathleen k schoemaker owner princetonjohn patrick shannon jrmorristownjohn patrick shannon jrchief commercial officer chicagojohn patrick shannon jrchief commercial officer chicagosofinnova management vii llcmenlo parksofinnova venture partners vii l pmenlo parkgeorge harrison talbotmorristownjesse i treu owner princetonronald irving trustmorristownronald irving trustchicagonicole vitullodirector princetonwendy l yarnochicagowendy l yarnodirector chicago potentially same personnamecitycountrynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorkny new leaf venture partners ii lp private company information  bloomberg july    am et capital markets company overview of new leaf venture partners ii lp snapshot people company overview new leaf venture partners ii lp specializes in incubation early mid and late stage investments the fund also invests in pipes transactions it seeks to invest in healthcare technology and life science sector with a focus on clinical stage biopharmaceutical products early stage medical devices molecular diagnostics and laboratory infrastructure at a variety of stages the fund prefers to invest between  million and  million in its portfolio companies times square tower times squaresuite new york ny united statesfounded in  phone  fax  key executives for new leaf venture partners ii lp dr philippe o chambon md phd managing director age  ms jeani delagardelle managing director mr vijay k lathi managing director age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact new leaf venture partners ii lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close insider trading  new leaf ventures ii lp  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  new leaf ventures ii lp select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm irhythm technologies inc irtc new leaf ventures ii lpdelagardelle jeanihunt ronaldratcliffe liamnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe o owner    direct view sale  pm mei pharma inc meip new leaf ventures ii lpnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe ohunt ronaldlathi vijay kdelagardelle jeaniratcliffe liam owner    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing conversion  pm nana irhythm technologies inc irtc new leaf ventures ii lpdelagardelle jeanihunt ronaldratcliffe liamnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe o owner   direct view conversion  pm nana irhythm technologies inc irtc new leaf ventures ii lpdelagardelle jeanihunt ronaldratcliffe liamnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe o owner   direct view conversion  pm nana irhythm technologies inc irtc new leaf ventures ii lpdelagardelle jeanihunt ronaldratcliffe liamnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe o owner   direct view conversion  pm nana irhythm technologies inc irtc new leaf ventures ii lpdelagardelle jeanihunt ronaldratcliffe liamnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe o owner   direct view conversion  pm  irhythm technologies inc irtc new leaf ventures ii lpdelagardelle jeanihunt ronaldratcliffe liamnew leaf venture associates ii lpnew leaf venture management ii llcchambon philippe o owner   direct view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  new leaf ventures ii lp  current holdings  fintelio new leaf ventures ii lp current holdings from f d investornew leaf ventures ii lp current positions new leaf ventures ii lp has disclosed  total holdings in their latest sec filings this investor has not filed a f which indicates it has under m in assets under management aum this investor has filed  activist d filings recently which suggests it takes an active role in influencing management new leaf ventures ii lp s top industries are chemicals and allied products sic   overview sec filings dg predictive value all new leaf ventures ii lp holdings are listed in the following table this data is sourced from dg and f filings green rows indicate new positions red rows indicate closed positions add this fundto your dashboard this is a list of d and g filings made since the last quarterly f report if any file dateformsecurity prevshares currentshares changepercent prev valuex current valuex changepercent ‑‑ sc ga irtc  irhythm technologies inc   ‑‑ sc da vsar  versartis inc   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now from the blog how to launch a hedge fund the piotroski score bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version new leaf ventures ii lp  lse lifescienceseuropecom  the european life sciences web portal zum inhalt home about us contact news people products deals organisations » follow us on twitter » get free newsletter top news diasorin to acquire elisa dx business from siemens mitsubishi tanabe to acquire neuroderm for b in cash evotec  bayer advance and extend endometriosis alliance gsk appoints laurie glimcher as noneexecutive director pharming completes refinancing with m debt facility » more news » submit your news   upcoming events citi�s th annual biotech conference  boston basel life  embo � miptec msacl  eu salzburg morgan stanley global healthcare conference  new york boaml global healthcare conference  london hupo  dublin th annual world congress smash  nmr conference baveno italy european biotech week  biopharm america  boston sachs annual biotech in europe forum  basel asebio investor day  barcelona european business development conference  heidelberg ebdc  worldlab  durban cphi worldwide  frankfurt bioeurope  berlin » more events » submit your event   bio regions  life sciences clusters biopro badenw�rttemberg gmbh flandersbio vzw scanbalt network scanbalt fmba biosaxony e v germany trade and invest � gesellschaft f�r au�enwirtschaft und standortmarketing mbh medicon valley alliance mva life science austria lisa service unit of austria wirtschaftsservice gmbh one nucleus mediwales ci cluster cluster f�r individualisierte immunintervention e v » more clusters and regions » submit your cluster or region   business parks  science centres izb innovations und gr�nderzentrum biotechnologie martinsried f�rdergesellschaft izb mbh genopole gip genopole technologiepark heidelberg gmbh parc cientific de barcelona bcp barcelona science park foundation campus vienna biocenter association vbc medeon science park oxford science park the leiden bio science park foundation biocity nottingham ltd london bioscience innovation centre lbic » more business parks » submit your business park   associations europabio � the european association of bioindustries bioindustry association bia gb emerging biopharmaceutical enterprises ebe france biotech asebio spanish bioindustry association bio deutschland e v european bioeconomy alliance eba » more associations » submit your association   partners » media partners » become a partner   advertisement organisation › detailsnew leaf ventures ii lphttpwwwnlvpartnerscom new leaf venture partners is a leader in healthcare technology venture investing our investment professionals bring a unique blend of technical clinical and operational experience to our investments working closely with our entrepreneurs and management teams to help build successful companies new leaf ventures invests in both public and private biopharmaceutical companies as well as healthcarerelated information technology companies new leaf currently manages over  billion in assets this includes nlv�s funds new leaf ventures i lp new leaf ventures ii lp new leaf ventures iii lp and new leaf growth fund i lp new leaf was formed in  as the healthcare spinoff from the sprout group one of the oldest us venture capital funds    start  existent   group new leaf venture partners nlv partners industry venture capital   industry  life sciences         city  menlo park ca     address record changed        basic data employees n a            document for �about section� harpoon therapeutics inc  press release harpoon therapeutics announces completion of m series b financing south san francisco ca           record changed  advertisement more documents for new leaf venture partners nlv partners  crispr therapeutics ag  press release crispr therapeutics raises additional m as part of series b financing basel  cambridge ma to subscribe to our free monthly newsletter for the european life sciences please send an email to infoiitode and simply fill the subject line with the word �lse newsletter� to get even more information please take a look at our gs professional services offering and read the genesensor product flyer pdf file advertisement » top advertisements � imprint    � contact    the use of this website requires to accept the disclaimer     a project of iito business intelligence   made in germany new leaf ventures ii lp sc da filing concerning vsar on  whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active schedule da filed by new leaf ventures ii lp total shares  subject company versartis inc   view complete ownership history backtest filed as of date  event date  overall  ownership  reporting persons name solevoting power sharedvoting power soledispositive power shareddispositive power aggregateamount owned percentof class new leaf ventures ii lp       new leaf venture associates ii lp       new leaf venture management ii llc       philippe o chambon       vijay lathi       ronald hunt       jeani delagardelle       liam ratcliffe       view original filing on edgars raw filing contents txt   hdrsgml    accession number  conformed submission type sc da public document count  filed as of date  date as of change  group members jeani delagardelle group members liam ratcliffe group members new leaf venture associates ii lp group members new leaf venture management ii llc group members philippe o chambon group members ronald hunt group members vijay lathi subject company company data company conformed name versartis inc central index key  standard industrial classification pharmaceutical preparations  irs number  fiscal year end  filing values form type sc da sec act  act sec file number  film number  business address street   bohannon drive street  suite  city menlo park state ca zip  business phone  mail address street   bohannon drive street  suite  city menlo park state ca zip  filed by company data company conformed name new leaf ventures ii lp central index key  irs number  state of incorporation de fiscal year end  filing values form type sc da business address street  times square tower street   times square suite  city new york state ny zip  business phone   mail address street  times square tower street   times square suite  city new york state ny zip  sc da  ddscdahtm sc da sc da     united states securities and exchange commission washington dc      schedule d under the securities exchange act of  amendment no      versartis inc name of issuer common stock  par value per share title of class of securities l cusip number craig l slutzkin new leaf venture management ii llc times square tower  times square suite  new york ny    name address and telephone number of person authorized to receive notices and communications november   date of event which requires filing of this statement     if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of §§de df or dg check the following box  ☐     note schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits see §d for other parties to whom copies are to be sent        the remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page the information required on the remainder of this cover page shall not be deemed to be filed for the purpose of section  of the securities exchange act of  act or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number       cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   new leaf ventures ii lp      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   wc      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   delaware limited partnership number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   pn cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   new leaf venture associates ii lp      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   delaware limited partnership number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   pn cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   new leaf venture management ii llc      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   delaware limited liability company number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   oo cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   philippe o chambon      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states citizen number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   in cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   vijay lathi      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states citizen number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   in cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   ronald hunt      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states citizen number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   in cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   jeani delagardelle      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states citizen number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   in cusip no l    d    page  of  pages         names of reporting persons irs identification nos of above persons entities only   liam ratcliffe      check the appropriate box if a member of a group see instructions   a  ☐        b  ☐      sec use only        source of funds see instructions   af      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states citizen number of shares beneficially owned by each reporting person with             sole voting power    shares          shared voting power    shares          sole dispositive power    shares        shared dispositive power    shares    aggregate amount beneficially owned by each reporting person    shares    check if the aggregate amount in row  excludes certain shares see instructions   ☐    percent of class represented by amount in row        type of reporting person see instructions   in cusip no l    d    page  of  pages   schedule d item  security and issuer this amendment no  to the statement on schedule d this amendment no  amends and supplements the statement on schedule d filed on april   the original d and together with amendment no  amendment no  and amendment no  the schedule d relates to the common stock  par value the common stock of versartis inc the issuer having its principal executive office at  bohannon drive suite  menlo park ca  certain terms used but not defined in this amendment no  have the meanings assigned thereto in the original d and amendment no  and amendment no  thereto except as specifically provided herein this amendment no  does not modify any of the information previously reported on the original d and amendment no  and amendment no  thereto item  identity and background this statement is being filed by new leaf ventures ii lp nlv ii new leaf venture associates ii lp nlv associates and new leaf venture management ii llc nlv management and together with nlv ii and nlv associates the reporting entities and philippe o chambon chambon vijay lathi lathi ronald hunt hunt jeani delagardelle delagardelle and liam ratcliffe ratcliffe and together with chambon lathi hunt and delagardelle the managing directors the reporting entities and the managing directors collectively are referred to as the reporting persons the address of the principal business office of nlv ii nlv associates nlv management chambon hunt and ratcliffe is new leaf venture partners times square tower  times square suite  new york ny  the address of the principal business office of lathi and delagardelle is new leaf venture partners  park place suite  san mateo ca  the principal business of nlv ii is to make hold and dispose of equity and equityrelated investments principally in healthcare medical device and life sciences companies the principal business of nlv associates is to act as the sole general partner of nlv ii the principal business of nlv management is to act as the sole general partner of nlv associates the principal business of each of the managing directors is to manage the reporting entities and a number of affiliated partnerships with similar businesses during the five years prior to the date hereof none of the reporting persons has been convicted in a criminal proceeding or has been a party to a civil proceeding ending in a judgment decree or final order enjoining future violations of or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws each of nlv ii and nlv associates is a limited partnership organized under the laws of the state of delaware nlv management is a limited liability company organized under the laws of the state of delaware each managing director is a citizen of the united states item  interest in securities of the issuer     a nlv ii is the record owner of  shares of common stock nlv ii shares as the sole general partner of nlv ii nlv associates may be deemed to own beneficially the nlv ii shares as the sole general partner of nlv associates nlv management may be deemed to own beneficially the nlv ii shares as the individual managers of nlv management each of the managing directors also may be deemed to own beneficially the nlv ii shares cusip no l    d    page  of  pages   each of the reporting persons may be deemed to own beneficially  of the issuers common stock which percentage is calculated based on  shares of the issuers common stock issued and outstanding as of november   as reported in the issuers form q filed with the us securities and exchange commission on november   each of the reporting persons except nlv ii disclaims beneficial ownership of the nlv ii shares except to the extent of their pecuniary interest therein if any     b regarding the number of shares as to which such person has     i sole power to vote or to direct the vote see line  of cover sheets     ii shared power to vote or to direct the vote see line  of cover sheets     iii sole power to dispose or to direct the disposition see line  of cover sheets     iv shared power to dispose or to direct the disposition see line  of cover sheets     c except as set forth in item  above none of the reporting persons has effected any transaction in the common stock during the last  days     d no other person is known to have the right to receive or the power to direct the receipt of dividends from or any proceeds from the sale of shares beneficially owned by any of the reporting persons     e not applicable item  material to be filed as exhibits exhibit   agreement regarding filing of joint schedule d exhibit   powers of attorney regarding schedule d filings cusip no l    d    page  of  pages   signature after reasonable inquiry and to the best of its knowledge and belief each of the undersigned certifies that the information set forth in this statement is true complete and correct date november   new leaf ventures ii lp   by   new leaf venture associates ii lp general partner by   new leaf venture management ii llc general partner by                                                                                 craig l slutzkin   chief financial officer new leaf venture associates ii lp by   new leaf venture management ii llc general partner by                                                                     craig l slutzkin   chief financial officer new leaf venture management ii llc by                                                                     craig l slutzkin   chief financial officer                                                                   philippe o chambon                                                                   vijay lathi                                                                   ronald hunt cusip no l    d    page  of  pages                                                                       jeani delagardelle                                                                       liam ratcliffe       s craig l slutzkin   craig l slutzkin   as attorneyinfact    this schedule d was executed by craig l slutzkin on behalf of the individuals listed above pursuant to powers of attorney copies of which are attached as exhibit  elevate your investments try it for free harpoon therapeutics announces completion of m series b financing  business wire harpoon therapeutics announces completion of m series b financing mpm capital arix bioscience new leaf venture partners and taiho ventures participate in immunooncology financing may    am eastern daylight time south san francisco califbusiness wireharpoon therapeutics a biotechnology company developing novel tcell recruiting biologic therapies for the treatment of cancer today announced the completion of a m series b financing which included arix bioscience new leaf venture partners and taiho ventures who are all new investors in the company and existing investor mpm capital the financing was coled by arix bioscience and new leaf venture partners mark chin investment manager at arix and ron hunt managing director at new leaf will join the harpoon therapeutics board of directors in addition sakae asanuma president of taiho ventures will join the board of directors in an observer capacity proceeds from the financing will be used to advance harpoon therapeutics’ novel proprietary trispecific tcell activating construct tritac™ immunooncology platform including moving two lead programs into clinical trials and expanding the product pipeline through discovery and partnering initiatives in addition the company is increasing its commitment to developing additional therapeutic platforms including those that become activated by proteases present in the tumor microenvironment “we are delighted to have toptier investors supporting the series b financing and welcome new investors as harpoon shareholders” said jerry mcmahon phd president and chief executive officer of harpoon therapeutics “this investment is a clear validation of harpoon’s tritac™ platform which offers a new way to unleash the targeted cellkilling properties of a patient’s own immune system with a potential bestinclass tcell engager platform” “we have been strong advocates of harpoon therapeutics from inception and are pleased to participate in this latest round of financing which provides capital to transition harpoon to a clinicalstage company as well as to advance critical discovery and research efforts” said luke evnin phd cofounder and chairman of harpoon and founder and managing director at mpm capital “harpoon therapeutics has a novel tcell engager platform which we believe will be instrumental to the discovery and development of important new therapeutics in oncology” said mark chin investment manager at arix bioscience a global healthcare and life science company supporting medical innovation “coupled with its scientific expertise and strong management team harpoon is wellpositioned to play a leading role in the immunooncology field” “new leaf looks for experienced management teams strong science and highimpact clinical benefit potential all of which harpoon therapeutics significantly offers” said ron hunt managing director at new leaf venture partners a leader in healthcare investing “we are pleased to be coleading this harpoon investment with arix and look forward to helping the company make important strides as it continues to advance its pipeline” harpoon’s first clinical candidate hpn is a prostatespecific membrane antigen psmatargeting tritac™ hpn is in development for the treatment of metastatic prostate cancer and is expected to enter phase  clinical trials in  the company anticipates identifying and moving into development additional clinical candidates within the next year about harpoon therapeutics — harpoon therapeutics is an immunooncology company founded by patrick baeuerle phd a pioneer in the development of tcell engaging therapies and mpm capital the company is focused on the discovery and development of novel tcell engaging biologics for the treatment of cancer and other diseases harpoon therapeutics created a novel antibodybased drug discovery platform called tritac™ trispecific tcell activating construct to unleash the targeted cellkilling properties of a patient’s own immune system through tcell activation this approach has been optimized to penetrate tissues and extend serum exposure and has the potential to address a broad range of cancers including solid tumors and immunologic diseases hpn a prostatespecific membrane antigen psmatargeting tritac™ biologic is in development for the treatment of prostate cancer and is expected to enter a clinical trial in  for more information please visit wwwharpoontxcom about mpm capital — mpm capital is an earlystage life sciences venture firm founding and investing in companies that seek to cure major diseases by translating scientific innovations into positive clinical outcomes mpm’s portfolio of companies aims to revolutionize the face of medicine across multiple areas including cancer diabetes obesity pain ehealth and more with its experienced and dedicated team of operating executives and medical and scientific advisory board mpm is powering novel medical breakthroughs that transform patients’ lives mpm is currently investing from two funds ─ the bv and ubs oncology impact fund for further information please visit wwwmpmcapitalcom about arix bioscience plc arix bioscience plc is a global healthcare and life science company supporting medical innovation headquartered in london and with an office in new york arix bioscience sources finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies arix bioscience plc is listed on the main market of the london stock exchange for further information please visit wwwarixbiosciencecom about nlv partners new leaf venture partners is a leader in healthcare technology venture investing our investment professionals bring a unique blend of technical clinical and operational experience to our investments working closely with our entrepreneurs and management teams to help build successful companies new leaf ventures invests in both public and private biopharmaceutical companies as well as healthcarerelated information technology companies new leaf currently manages over  billion in assets this includes nlv’s funds new leaf ventures i lp new leaf ventures ii lp new leaf ventures iii lp and new leaf growth fund i lp new leaf was formed in  as the healthcare spinoff from the sprout group one of the oldest us venture capital funds for more information please visit wwwnlvpartnerscom about taiho ventures llc taiho ventures llc is the strategic corporate venture capital arm of taiho pharmaceutical co ltd a japanese specialty pharma focusing on oncology allergy and immunology and urology taiho ventures is a newlyestablished strategic investor looking at early stage preclinical oncology companies as well as platform technology companies for our core therapeutic areas taiho ventures will review the wide variety of modalities for both biologics and small molecules mainly in us and european countries the company will also consider the optiontype of investments and spinouts in addition to the pure equity investments for more information about taiho ventures please visit wwwtaihoventurescom contacts for harpoon therapeuticskinkead communications incsusan kinkead susankinkeadcommcom release summary harpoon therapeutics announces m series b financing contacts for harpoon therapeuticskinkead communications incsusan kinkead susankinkeadcommcom search advanced news search advanced news search log in sign up nlvpartners  funding the healthcare revolution new leaf venture partners funding the healthcare revolution yelp yelp sorry you’re not allowed to access this page contact yelp if you keep experiencing issues bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one